Skip to main content
Premium Trial:

Request an Annual Quote

David Lasecki

GenomOncology has appointed David Lasecki as chief commercialization officer. In this position, Lasecki will lead the company's growth strategy by working with key stakeholders in the healthcare industry to promote the widespread adoption of precision medicine. Most recently, he served as president of CompanionDx Labs and additionally presided over the commercialization of CompanionDx's oncology-specific DNA sequencing and pharmacogenomics tests. Lasecki has also held a variety of sales and new business development roles with AmerisourceBergen's specialty group, the International Oncology Network.